Biofrontera BFRI
NASDAQ BFRI
$1.09 -0.04 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Notes Payables (2023 - 2024)

Updated

Biofrontera (BFRI) recorded Notes Payables of $296,000 in Q2 2024, down 87.4% from the prior quarter.

Analysis

Biofrontera (BFRI) Notes Payables (2023 - 2024) Analysis & Trends

At the end of FY2023, Biofrontera reported Notes Payables of $3.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Biofrontera 16.05 Mn -5.74 Mn 9.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 296,000.00
Mar 31, 2024 2.36 Mn
Dec 31, 2023 3.90 Mn
API Access

Biofrontera Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BFRI&period=max&api_key=YOUR_API_KEY